Clinical and Radiologic Disease Activity in Pregnancy and Postpartum in MS
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received August 14, 2020
- Accepted in final form December 14, 2020
- First Published February 19, 2021.
Author Disclosures
- Annika Anderson, BA,
- Kristen M. Krysko, MD, MAS (annika.anderson{at}ucsf.edu),
- Alice Rutatangwa, DO, MSc (alice.rutatangwa{at}ucsf.edu),
- Tanya Krishnakumar, BA,
- Chelsea Chen (tanyakris{at}gmail.com),
- William Rowles, BA,
- Chao Zhao, MS,
- Maria K. Houtchens, MD and
- Riley Bove, MD, MSc (william.rowles{at}ucsf.edu)
- Annika Anderson, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Kristen M. Krysko, MD, MAS (annika.anderson{at}ucsf.edu),
NONE
NONE
(1) National Multiple Sclerosis Society, Travel Grant, (2) ACTRIMS, Travel Grant, (3) ECTRIMS, Travel Grant, (3) Biogen, Inc., (4) Normative, Inc.
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
(1) Fellowship support from Biogen, Idec.
NONE
NONE
(1) Fellowship support from the National Multiple Sclerosis Society (Sylvia Larry Physician Fellowship, FP-1605-08753).
NONE
NONE
NONE
NONE
NONE
NONE
- Alice Rutatangwa, DO, MSc (alice.rutatangwa{at}ucsf.edu),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I have received funding to support MS fellowship from Biogen
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Tanya Krishnakumar, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chelsea Chen (tanyakris{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- William Rowles, BA,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Chao Zhao, MS,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Maria K. Houtchens, MD and
Served on a scientific advisory board for EMDSerono, Biogen Idec, Teva Neuroscience, Roche Genentech, Sanofi Genzyme, Mallinckrodt pharmaceuticals
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Compensated non-promotional journal club presentations and slide deck preparations: Novartis (2010), Serono (2019, 2020)
NONE
Sanofi Genzyme (investigator-initiated research funding) Biogen (investigator-initiated research funding) Serono (collaborative agreement research funding)
CDC consultant on subject of guidelines for contraception for MS patients (2015)
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Riley Bove, MD, MSc (william.rowles{at}ucsf.edu)
(1) Roche-Genentech (2) Sanofi Genzyme (3) Novartis (4) EMD Serono (5) Alexion (6) Pear Digital Therapeutics (7) Biogen
NONE
NONE
NONE
(1) Patent - selective estrogen receptor modulators and remyelination.
NONE
NONE
(1) Roche-Genentech (2) Sanofi Genzyme (3) Novartis (4) EMD Serono (5) Alexion (6) Pear Digital Therapeutics (7) Biogen
NONE
NONE
NONE
(1) Commercial entity, Akili Interactive (2) Commercial entity, Roche Genentech (3) commercial entity, Biogen
NONE
(1) UCSF Medical staff (10/2015-current)
(1) National MS Society, Career Transition Award (2) National MS Society, Research Award (3) National MS Society, Pilot Grant (4) Hilton Foundation Research Grant (5) Sherak Foundation (6) National MS Society, Harry Weaver Award
NONE
(1) Patent - selective estrogen receptor modulators and remyelination.
NONE
NONE
NONE
NONE
- From the Weill Institute for Neurosciences (A.A., K.M.K.), Department of Neurology, University of California San Francisco, San Francisco, CA; Department of Neurology (K.M.K., R.B.), School of Medicine, University of California San Francisco, San Francisco, CA; Weill Institute for Neurosciences (A.R., T.K., C.C., W.R., C.Z., R.B.), Department of Neurology, University of California San Francisco, San Francisco, CA; Department of Neurology (M.H.), Brigham and Womens Hospital, Harvard Medical School, Boston MA.
- Correspondence
Dr.Bove riley.bove{at}ucsf.edu
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Article
Pregnancy-related relapses and breastfeeding in a contemporary multiple sclerosis cohortAnnette Langer-Gould, Jessica B. Smith, Kathleen B. Albers et al.Neurology, April 13, 2020 -
Article
Disease activity following pregnancy-related discontinuation of natalizumab in MSIris Kleerekooper, Zoé L.E. van Kempen, Cyra E. Leurs et al.Neurology: Neuroimmunology & Neuroinflammation, December 06, 2017 -
Article
MRI activity in MS and completed pregnancyData from a tertiary academic centerMaria Houtchens, Riley Bove, Brian Healy et al.Neurology: Neuroimmunology & Neuroinflammation, September 11, 2020 -
Articles
Breastfeeding is not related to postpartum relapses in multiple sclerosisE. Portaccio, A. Ghezzi, B. Hakiki et al.Neurology, July 06, 2011